|
Volumn 8, Issue 12, 2012, Pages 1743-1744
|
Chinese biotech partnership brings first hepatitis E vaccine to the market.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HECOLIN;
HEPATITIS VACCINE;
RECOMBINANT VACCINE;
CHINA;
DRUG APPROVAL;
HEPATITIS E;
HUMAN;
IMMUNOLOGY;
NOTE;
PUBLIC-PRIVATE PARTNERSHIP;
CHINA;
DRUG APPROVAL;
HEPATITIS E;
HUMANS;
PUBLIC-PRIVATE SECTOR PARTNERSHIPS;
VACCINES, SYNTHETIC;
VIRAL HEPATITIS VACCINES;
|
EID: 84892545756
PISSN: None
EISSN: 2164554X
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (10)
|
References (0)
|